Day One Biopharmaceuticals (DAWN)
US Market

Day One Biopharmaceuticals Financial Statements


Day One Biopharmaceuticals Financial Overview

Day One Biopharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.741; its P/E ratio is -11.52; Day One Biopharmaceuticals is scheduled to report earnings on November 7, 2022, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -36.72M$ -27.75M$ -21.95M$ -19.23M$ -15.47M
EBITDA$ -36.59M$ -27.70M$ -21.89M$ -19.18M$ -15.42M
Net Income Common Stockholders$ -36.53M$ -27.75M$ -21.94M$ -19.24M$ -114.28M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 43.73M$ 154.87M$ 262.73M$ 284.31M$ 297.16M
Total Assets$ 404.05M$ 267.78M$ 289.82M$ 303.78M$ 316.54M
Total Debt$ 171.00K$ 214.00K$ 264.00K$ 313.00K$ 361.00K
Net Debt$ -43.56M$ -154.66M$ -262.47M$ -284.00M$ -296.80M
Total Liabilities$ 13.42M$ 8.18M$ 8.67M$ 6.11M$ 4.77M
Stockholders Equity$ 259.60M$ 281.15M$ 297.67M$ 311.76M$ 390.63M
Cash Flow
Free Cash Flow$ -29.79M$ -21.58M$ -13.17M$ -12.22M$ -13.41M
Operating Cash Flow$ -29.79M$ -21.56M$ -13.17M$ -12.22M$ -13.41M
Investing Cash Flow$ -6.00M$ -15.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 161.93M$ 0.00$ 318.00K$ -615.00K$ 168.53M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

Day One Biopharmaceuticals Debt to Assets

Day One Biopharmaceuticals Cash Flow

Day One Biopharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis